本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Galmed Pharmaceuticals

4.63
0.0000
成交量:- -
成交額:- -
市值:482.26萬
市盈率:-0.33
高:4.63
開:4.63
低:4.63
收:4.63
52周最高:13.20
52周最低:3.29
股本:104.16萬
流通股本:97.47萬
量比:4.33
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-14.1059
每股收益(LYR):-19.1292
淨資產收益率:-68.21%
總資產收益率:-30.19%
市淨率:0.38
市盈率(LYR):-0.24

資料載入中...

2026/04/01

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/09/19

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/08/21

SEC問詢函

Form CORRESP - Correspondence
2025/08/18

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/04/03

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/01/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/20

SEC問詢函

Form CORRESP - Correspondence
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/29

SEC問詢函

Form CORRESP - Correspondence
2024/10/21

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/09/20

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/20

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/09

SEC問詢函

Form CORRESP - Correspondence
2024/08/30

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/04/04

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/07/21

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/07/14

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]